Newsletter | October 5, 2026

10.05.26 -- Solving Glycoengineering Challenges Could Begin At The Cell Line

SPONSOR

 

Webinar: Scaling ADC manufacturing without compromising quality

Scaling ADC programs from clinical to commercial manufacturing brings new challenges in mixing, solvent distribution, hydrophobicity, and process control. This webinar explores practical strategies and digital tools to reduce scale-up risk, including CFD modeling for conjugation, membrane strategies for TFF, and SIMCA®-online for multivariate process control, batch genealogy, and golden batch monitoring. Discover approaches to improve consistency, robustness, and efficiency across ADC manufacturing. Click here to learn more.

FOCUS ON UPSTREAM MANUFACTURING

Solving Glycoengineering Challenges Could Begin At The Cell Line

Researchers produced a panel of platform cell lines illustrating how glycoform selection can be made experimentally visible earlier in biologics development.

 

 

Keys To Achieving Unparalleled Flexibility In CHO Based Bioproduction

The dynamic growth and pace of change observed in novel mAb formats and cell and gene therapies emphasizes that biomanufacturing innovation is essential to deliver scale, speed, and sustainability.

 

Overcoming Cell Therapy Manufacturing Risks And Barriers

Achieve scalable MSC manufacturing by implementing closed systems and modular scale-out strategies that minimize contamination risks and ensure consistent cellular stability and efficacy.

 

Accelerating Antibody Development: A Proven Path From Gene To GMP

Discover how an optimized, end-to-end development strategy can help sponsors reach key clinical milestones faster and bring potentially life-saving therapies to patients sooner.

 

Beyond Breakdowns: Building A Culture Of Proactive Maintenance

Reactive maintenance can drive costly downtime, deviations, and reliability challenges. See how proactive maintenance strategies help improve equipment uptime and strengthen compliance.

 

Secure Your Custom Media Supply With Capacity And Quality You Can Trust

A resilient media supply strategy helps reduce operational risk. Take a look at how scalable manufacturing, quality alignment, and supplier qualification can strengthen continuity.

 

Stable Bulk Cultures: A Fast Path To Antibody Manufacturing

The potential advantages that stable bulk cultures can offer a drug development paradigm are poised to accelerate and bolster biopharmaceutical clinical manufacturing.

 

Maximizing Safety And Efficacy In Hematopoietic Stem Cell Gene Therapy

Advances in automated stem cell engineering are improving gene transfer efficiency while maintaining cell quality, offering a path toward safer, more standardized, and scalable manufacturing workflows.

 

Industrializing iPSC Feed Streams Via Process Parameter And Optimization

Explore how an optimized bioprocess with purpose-designed medium and GMP-compatible reagents achieved 10,000-fold iPSC expansion in under two weeks while maintaining pluripotency.

 

Comparing Use, Process, And Reproduction Of Two Fermentation Systems

Maximize your yield by choosing systems with active pH and oxygen control. Learn how environmental stability and strain diversity impact reproducibility during high-temperature yeast propagation.

 

A Beginner's Guide To Mesenchymal Stem Cell Culture

Gain a foundational understanding of the process for culturing mesenchymal stem cells in stirred-tank bioreactors and learn about the key parameters for successful scale-up.

 

Characterizing Robustness In An End-To-End Cryopreserved Workflow

A systematic evaluation of an end-to-end cryopreserved CAR-T workflow examines how critical process parameters and unit operation interdependencies affect manufacturing consistency and robustness.

UPSTREAM MANUFACTURING SOLUTIONS

•

Accelerating A Promising Bispecific Antibody To The Clinic - AGC Biologics

•

Breaking Productivity Barriers In Upstream Bioprocessing - Repligen

•

Enabling Large-Scale Lentivirus Manufacturing With A Reliable Stabilizer - Mirus Bio

SPONSOR

 

Webinar: Beyond Fed-Batch: Choosing the Right Path to Process Intensification

How can biomanufacturers increase capacity without expanding their footprint? This webinar explores upstream process intensification strategies, from intensified fed-batch to continuous manufacturing. Discover how the right approach can drive 5–10× higher cell densities and 2–10× higher product titers while improving bioreactor utilization. Explore case studies and economic trade-offs to optimize productivity, reduce COGs, and support scalable manufacturing. Click here to learn more.

Connect With Bioprocess Online: